细胞外囊泡微小RNA组谱分析揭示代谢功能障碍相关脂肪性肝病患者微小RNA参与脂质代谢异常、慢性炎症和肝损伤
本研究对228例经活检证实的代谢功能障碍相关脂肪性肝病(MASLD)患者进行细胞外囊泡(EV)微小RNA(miRNA)组谱分析,并在54例亚组中开展体内代谢研究。结果发现7种miRNA与脂肪性肝炎诊断及显著纤维化(F≥2)相关,标志「高危MASH」;其中miR-122-5p和miR-375-3p与游离脂肪酸及脂肪组织胰岛素抵抗(AT-IR)直接相关,let-7d-5p和let-7f-5p与脂解、游离脂肪酸及促炎细胞因子呈负相关,并随AT-IR严重程度逐渐降低。结论提示这些miRNA在「高危MASH」患者的脂质代谢紊乱和炎症通路中相互交织,为后续研究其潜在治疗价值奠定基础。
要点
- 7种EV miRNA(miR-27b-3p、miR-30a-5p、miR-122-5p、miR-375-3p、miR-103a-3p、let-7d-5p、let-7f-5p)与脂肪性肝炎诊断及显著纤维化(F≥2)相关,标志「高危MASH」。
- miR-122-5p和miR-375-3p水平与循环游离脂肪酸及脂肪组织胰岛素抵抗直接相关。
- let-7d-5p和let-7f-5p与脂解、游离脂肪酸及循环和肝脏促炎细胞因子表达呈负相关,并随AT-IR严重程度逐渐降低。
核心结论
- 结果提示miR-122-5p、miR-375-3p与let-7家族在「高危MASH」患者的脂质代谢紊乱和炎症通路调节中相互交织,为后续研究其潜在治疗价值奠定基础。
研究设计与样本
- 在228例经活检证实的MASLD患者中,采用NGS(NextSeq550,Illumina Inc)检测EV miRNA表达。
- 在54例患者亚组中,通过示踪剂输注([6,6-2H2]葡萄糖和[2H5]甘油)进行体内代谢研究,评估葡萄糖和脂质通量及脂肪组织胰岛素抵抗。
主要发现
- 7种miRNA(miR-27b-3p、miR-30a-5p、miR-122-5p、miR-375-3p、miR-103a-3p、let-7d-5p和let-7f-5p)根据脂肪性肝炎诊断及显著纤维化(F≥2)的存在呈现差异表达,从而标志「高危MASH」受试者。
- 在代谢研究中,上述miRNA与脂质代谢的关联最强:miR-122-5p和miR-375-3p水平与循环游离脂肪酸(FFAs)及脂肪组织胰岛素抵抗(AT-IR)直接相关。
- let-7d-5p和let-7f-5p与脂解、FFAs呈负相关,并随AT-IR严重程度逐渐降低。
- let-7d-5p和let-7f-5p与循环和肝脏促炎细胞因子表达呈负相关,而促炎细胞因子随AT-IR程度增加而升高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: MicroRNAs (miRNAs) are short non-coding oligonucleotides involved in the post-transcriptional regulation of gene expression. We investigated the association between the miRNome profile of circulating extracellular vesicles (EVs) and metabolic derangements, circulating and hepatic pro-inflammatory cytokines, and liver damage across the histological spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD). METHODS: EV miRNAs expression was determined by NGS (NextSeq550, Illumina Inc) in 228 biopsy-proven MASLD patients. In vivo metabolic studies were performed in a subgroup of 54 patients by tracer infusion ([6,6-2H2]glucose and [2H5]glycerol) to assess glucose and lipid fluxes and insulin resistance (IR) in the adipose tissue. RESULTS: Seven miRNAs (miR-27b-3p, miR-30a-5p, miR-122-5p, miR-375-3p, miR-103a-3p, let-7d-5p, and let-7f-5p) were differentially expressed according to the diagnosis of steatohepatitis and the presence of significant fibrosis (F ≥ 2), thus marking subjects with 'at-risk MASH'. In the metabolic studies, the above-reported miRNAs had the strongest associations with lipid metabolism: miR-122-5p and miR-375-3p levels directly correlated with circulating free fatty acids (FFAs) and adipose tissue (AT)-IR, while let-7d-5p and let-7f-5p inversely correlated with lipolysis, FFAs, and progressively decreased according to AT-IR severity. In addition, let-7d-5p and let-7f-5p inversely correlated with the circulating and hepatic expression of pro-inflammatory cytokines, which increased by increasing degrees of AT-IR. CONCLUSIONS: Our results suggest an intertwined connection between miR-122-5p, miR-375-3p, and the let-7 family in modulating lipid derangements and inflammatory pathways in patients with 'at-risk MASH', paving the basis for further studies aiming at investigating their potential therapeutic value.
引用
- Caviglia GP, Casalone E, Rosso C, et al. Extracellular Vesicles miRNome Profiling Reveals miRNAs Engagement in Dysfunctional Lipid Metabolism, Chronic Inflammation and Liver Damage in Subjects With Metabolic Dysfunction-Associated Steatotic Liver Disease. Aliment Pharmacol Ther. 2025. PMID: 40208030. doi:10.1111/apt.70150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。